..

Which stocks are soaring or sinking today? From 3M’s big leap to Northrop’s dip, uncover the midday moves shaking up the market. Click to find out what’s next!

After two rejections, Replimune is resubmitting its promising melanoma drug following major FDA leadership changes. Could this be the breakthrough patients have been waiting for, and what does it signal for the broader biotech sector?

A federal judge just ordered the destruction of pivotal evidence in the case against former FBI Director James Comey. With deadlines looming and appeals in play, is this the end of accountability or a blatant interference? The implications are huge...